VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) was down 23.3% on Saturday . The company traded as low as C$0.12 and last traded at C$0.12. Approximately 1,797,794 shares traded hands during trading, an increase of 540% from the average daily volume of 280,948 shares. The stock had previously closed at C$0.15.
VentriPoint Diagnostics Stock Down 23.3 %
The company has a market capitalization of C$18.65 million, a price-to-earnings ratio of -3.55 and a beta of 0.39. The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67. The firm’s fifty day moving average price is C$0.10 and its 200-day moving average price is C$0.13.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Further Reading
- Five stocks we like better than VentriPoint Diagnostics
- What is the S&P/TSX Index?
- Chaos and Cash: Finding Opportunity in Volatility
- Learn Technical Analysis Skills to Master the Stock Market
- Realty Income: An Anchor in Volatile Markets
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Autodesk Designs Value for Investors: Uptrend Set to Continue
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
